Yes, though staging sets the ceiling. Mild to moderate COPD in a non-smoker is often written as traditional cover with a rating; severe disease or supplemental oxygen generally moves the file to guaranteed issue or final expense.
COPD is underwritten on measured lung function rather than on how you describe your breathing, and that single fact changes how you should prepare.
The number that decides it
Underwriters work from spirometry, specifically FEV1 as a percentage of predicted. The GOLD staging system divides that into four bands: at or above 80% is mild, 50–79% moderate, 30–49% severe, below 30% very severe.
If you do not know your FEV1 percentage, that is the first thing to find out. It is on your spirometry report and it shapes the entire application. Applying without it is applying blind.
What else carriers weigh
Smoking status does more here than anywhere else — continuing to smoke with diagnosed COPD reads as unmanaged progressive disease rather than as two separate risk factors. Exacerbation history and hospital admissions matter, as do BMI and exercise tolerance, both of which are components of the BODE prognostic index carriers borrow from.
Realistic outcomes
Mild, no medication, non-smoker: traditional cover, sometimes near standard. Moderate on an inhaler: traditional cover with a table rating, and wide carrier spread. Severe on multiple medications: simplified issue territory. Oxygen: guaranteed issue and final expense.
The full treatment is on COPD and respiratory conditions, and the staging detail is in our guide to where staging sets the ceiling.
The full treatment of this topic is on COPD and respiratory.